Brain zap aftermath: can we map and avoid memory loss?

NCT ID NCT06466720

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tracks 80 patients with brain tumors (metastases or meningiomas) who receive stereotactic radiosurgery. Researchers use memory tests and quality-of-life questionnaires before treatment and every 3 months for a year to see if and how brain function changes. By comparing test results with MRI scans and radiation plans, they hope to pinpoint brain regions where reducing radiation could prevent cognitive decline.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors reduce radiation to brain areas that cause thinking problems, potentially improving quality of life for future patients.
What could go wrong
This is a small pilot study, so results may not apply to all patients. It only measures changes and does not test a new treatment, so direct benefits are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nottingham University Hospitals NHS Trust

    Nottingham, Nottinghamshire, NG5 1 PB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.